The members section of the ISH website is currently being upgraded.

We apologise that you cannot access it at present but we will be back online shortly.
In the meantime, please call the Secretariat with any questions on +44 (0) 20 8977 7997

International Society of Hypertension

ISH - Hero Image 1ISH - Hero Image 2ISH - Hero Image 3ISH - Hero Image 5ISH - Hero Image 6ISH - Hero Image 7ISH - Hero Image 8ISH - Hero Image 9ISH - Hero Image 10ISH - Hero Image 11ISH - Hero Image 12ISH - Hero Image 13ISH - Hero Image 14ISH - Hero Image 15

Our Officers & Committees

The society is comprised of a range of committees. These are charged with various responsibilities, but ultimately with the same aim of ensuring that it continues to grow and strengthen as the world's premiere blood pressure society, whilst ensuring that youth and developing countries are reflected where possible.

Professor Rhian Touyz (BHF Cardiovascular Research Centre, University of Glasgow, UK) commenced her ISH presidency on 15th June during the Hypertension Athens (Joint ESH-ISH) 2014 scientific meeting. Information on the revised committees for 2014-2016 will follow shortly.

Executive of Council

  • Ernesto Schiffrin/Vice-President & President-Elect

    Ernesto Schiffrin President

    Canada

    I carry out basic and clinical mechanistic and therapeutic research in high blood pressure, teaching and clinical practice in cardiovascular and internal medicine, and editorial activity in hypertension. I also head a department of medicine in a university hospital.

  • Louise Burrell/Treasurer

    Louise Burrell Vice President and Corporate Liaison Officer

    Australia

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

  • Agustin Ramirez /Ex-Officio ñ International Development

    Agustin Ramirez Secretary

    Argentina

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Roland Schmieder/Members

    Roland Schmieder Treasurer

    Germany

    I have extensive experience in the execution of clinical observational and international multicenter studies.

    My research interests include nephrology, hypertension, non-invasive cardiology and vascular medicine, with a focus on hypertensive damage to the heart, kidneys, arteries and retinal circulation and its treatment.

  • Stephen Harrap/President

    Stephen Harrap Immediate Past-President

    Australia

    My ongoing commitment to hypertension encompasses clinical (as a specialist physician), research (in human and experimental genetics of blood pressure and its complications) and teaching (as Chair of Physiology) perspectives.

    For more information on the President, click here

  • Bo Carlberg/Officer-at-Large - Young Investigators

    Bo Carlberg Officer at Large – Communications

    Sweden

    Areas of interest:

    • The epidemiology of hypertension
    • The hypertension-stroke connection
    • Blood Pressure in acute stroke Systematic Reviews
    • The process from research to guidelines for cardiovascular diseases in developing countries
  • Dorairaj Prabhakaran/Ex-Officio ñ International Development

    Dorairaj Prabhakaran Ex-Officio - International Development

    India

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence ñ Centre for Cardio-metabolic Risk Reduction in South Asiaî (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte New Investigators Liaison Officer

    South Africa

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Rhian Touyz/Secretary & Forum Officer

    Rhian Touyz President-Elect and Chair, Membership Committee

    UK

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

  • Ji-Guang Wang/Members

    Ji-Guang Wang International Development Officer

    China

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

Members of the Scientific Council

  • Guido Grassi/Members

    Guido Grassi

    Italy

    Areas of interest:

    • Pathophysiology of hypertension, with particular emphasis on the role of the Sympathetic Nervous System
    • Assessment of target organ damage
    • Blood pressure control
    • Guidelines on hypertension diagnosis and management
  • Hermann Haller/Members

    Hermann Haller

    Germany

    Main interests in clinical research:

    • diagnostics and treatment of renovascular hypertension
    • hypertension and the vasculature in diabetes
    • hypertension in organ transplantation
    • novel therapeutic devices such as carotid sinus stimulation and renal sympathetic nerve ablation Main interests in basic science
    • the biology of the vascular wall and endothelial function
    • endothelial cell permeability
    • cell adhesion and inflammation
    • stem cell precursors of the endothelium
  • Cheol-Ho-kim / Members

    Cheol-Ho Kim

    Korea

    I am the chief of the Geriatric Centre of Seoul National University Bundang Hospital, working as the Chair of Scientific Affairs for the organizing committee of the ISH 2016 in Seoul, as the Director of Planning for the Korean Society of Hypertension and as a member of the Board of Trustees of the Asian Pacific Society of Hypertension. My main interest is hypertension especially in the elderly and related clinical studies.

  • GÈrard London/Members

    Gérard London

    France

    I specialized in nephrology at Paris Medical School and am currently chief of the department of Nephrology-Hemodialysis of the Manhes Hospital. My main areas of interest concern cardiovascular physiology and pathophysiology and I have published more than 300 publications in peer review journals and several chapters in books in this field.

  • Basden Onwubere/Members

    Basden Onwubere

    Nigeria

    My area of interest in High Blood Pressure is in prevention and control. I am also interested in the effect of uncontrolled high blood pressure on the heart.

  • Neil Poulter/Members

    Neil Poulter

    UK

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Kazuaki Shimamoto/Members

    Kazuaki Shimamoto

    Japan

    My research interests are; Epidemiology of hypertension, etiology of hypertension especially the role of insulin resistance and adipocytokines, and treatment of hypertension especially the mechanisms of RAS inhibitory drugs.

  • Naftali Stern/Members

    Naftali Stern

    Israel

    Areas of interest and research include hormonal control of blood pressure and the vasculature with particular emphasis on the metabolic syndrome; role of sex hormones in arterial physiology; role of the lipoxygenase system in vascular cell signaling and growth, interaction between adipocytes and vascular cells.

  • Michael Weber/Chair

    Michael Weber

    U.S.A.

    I am involved in the contemporary practice of preventative cardiology, with a focus on hypertension. I am currently the editor of the Journal of Clinical Hypertension and so have an excellent opportunity to be aware of new developments and controversies in the field.

    I have a major interest in clinical trials in patients with hypertension or at high cardiovascular risk, and am particularly interested in how current evidence based on this research -- much of which is inconclusive -- can be used to help define hypertension and guide clinical practice.

    I have also been involved in the development of new drugs for treating hypertension and in understanding how they can be used to the greatest clinical advantage in our patients.

Ex-Officio Members of the Scientific Council

  • Norm Campbell/WHL Representative

    Norm Campbell WHL Representative

    Canada

    My current main interest is healthy public policy to prevent and control hypertension and the evaluating the epidemiology of hypertension in response to population interventions to prevent and control hypertension.

  • John Chalmers/ISH International Forum

    John Chalmers Planning

    Australia

    I have long been committed to research on hypertension and cardiovascular diseases, including studies of brain mechanisms in experimental hypertension and clinical trials assessing drug combinations for the treatment of hypertension.

    I am a Principal investigator for a number of major trials, including PROGRESS (in recurrent stroke), ADVANCE (in type 2 diabetes) and the INTERACT2 trial of more intensive blood pressure lowering in acute intracerebral haemorrhage.

  • Lewis Landsberg/Board of Management

    Lewis Landsberg Board of Management

    USA

    Areas of interest in relation to blood pressure:

    • Sympathetic nervous system
    • Obesity-related hypertension
    • The metabolic syndrome
  • Lars H. Lindholm/Hypertension News

    Lars H. Lindholm Hypertension News

    Sweden

    I have been President of the Swedish Society of Hypertension (1989-92), Secretary (the first) of the European Society of Hypertension, ESH (1989-97) , and President of the ISH (2006-8). Since 2009, I have been an honorary member of the British Society of Hypertension.

    My interest in hypertension and its risks started in the late 1970s and I defended my doctoral thesis on this topic in 1994. Since 1998, I am Professor and chairman at the Department of Public Health and Clinical Medicine at Umeå University, Sweden.

  • Trefor Morgan/APSH Representative

    Trefor Morgan APSH Representative

    Australia

    I am a Physiologist Clinician with experimental, and clinical involvement in Salt and water Metabolism and the renin angiotensin system. Trained as a nephrologist and cardiologist.

    Secretary General of the Asian Pacific Society of Hypertension.

  • Josep Redon/ESH Representative

    Josep Redon ESH Representative

    Spain

    Current President of the European Society of Hypertension. Physician, Full Professor of Internal Medicine and Researcher in the field of cardiovascular risk, specialising in the study of mechanisms and development of hypertension-induced organ damage. The most relevant aspects of our research are the following:

    • The search for early markers of organic damage in essential hypertension
    • Introduction and validation of ambulatory measurement techniques during 24-hours of blood pressure
    • Epidemiological Studies
  • Alberto Zanchetti/Board of Management

    Alberto Zanchetti Board of Management

    Italy

    I am Emeritus Professor of Medicine, University of Milan and Scientific Director, Istituto Auxologico Italiano, Milan, Past-President of ISH, and current Editor-in-Chief of the Journal of Hypertension.

    My major scientific interests are neural control of the circulation and the kidney, and antihypertensive treatment.

Regional Advisory Groups

To provide comprehensive representation and to distil regional issues, we have created Regional Advisory Groups (RAGs). Each RAG comprises, where appropriate, a mixture of members from developed and developing countries, so that the whole will be greater than the sum of the parts. There are now RAGs established as follows:

Africa

  • Robert Fagard /Chair

    Robert Fagard Chair

    Belgium

    Areas of interest:

    • BP measurement, target organ damage and prognosis
    • The heart in hypertension
    • Physiology and pathophysiology of exercise
    • Hypertension in the developing world.
  • Albertino Damasceno /Chair

    Albertino Damasceno Member

    Mozambique

    Areas of interest:

    • Epidemiology of Hypertension and risk factors
    • Stroke
    • Salt and Hypertension
    • 24 H monitoring of the Blood Pressure
  • GÈrard London/Members

    Gérard London Member

    France

    I specialized in nephrology at Paris Medical School and am currently chief of the department of Nephrology-Hemodialysis of the Manhes Hospital. My main areas of interest concern cardiovascular physiology and pathophysiology and I have published more than 300 publications in peer review journals and several chapters in books in this field.

  • Jean-Rene M'Buyamba-Kabungu/Members

    Jean-René M 'Buyamba-Kabungu Member

    D.R. Congo

  • Basden Onwubere/Members

    Basden Onwubere Member

    Nigeria

    My area of interest in High Blood Pressure is in prevention and control. I am also interested in the effect of uncontrolled high blood pressure on the heart.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte New Investigators Liaison Officer

    South Africa

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

Asia & Australasia

  • Trefor Morgan /Chair

    Trefor Morgan Chair

    Australia

    I am a Physiologist Clinician with experimental, and clinical involvement in Salt and water Metabolism and the renin angiotensin system. Trained as a nephrologist and cardiologist. Secretary General of the Asian Pacific Society of Hypertension.

  • Masatsugu Horiuchi Member

    Japan

  • Muhammad Ishaq /Chair

    Muhammad Ishaq Member

    Pakistan

    Areas of interest: Epidemiology, public education & management of Hypertension.

  • Tazeen Jafar Member

    Singapore

  • Dorairaj Prabhakaran/Members

    Dorairaj Prabhakaran Member

    India

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence ñ Centre for Cardio-metabolic Risk Reduction in South Asiaî (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Neil Poulter/Members

    Neil Poulter Member

    UK

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Ji-Guang Wang/Members

    Ji-Guang Wang Member

    China

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

Central & South America

  • Ernesto Schiffrin/Chair

    Ernesto Schiffrin Chair

    Canada

    I carry out basic and clinical mechanistic and therapeutic research in high blood pressure, teaching and clinical practice in cardiovascular and internal medicine, and editorial activity in hypertension. I also head a department of medicine in a university hospital.

  • Virginia Asin-Oostburg/Members

    Virginia Asin-Oostburg Member

    Sint Maarten

    Areas of interest: Human Resource Reform of health workers (medical and non medical) for Prevention, Management and Control of NCDís (e.g. Capacity building, strengthening, improvement and consolidation) in general but for Hypertension, Diabetes and Cardiovascular diseases in particular; Upgrading of research and scientific writing skills of health professionals; Population empowerment through community mobilization and self management of conditions.

  • Kennedy Cruickshank Member

    UK

  • Carlos Ferrario/Members

    Carlos Ferrario Member

    U.S.A

    My research career spans multiple important contributions dealing with exploring the biochemical and physiological mechanisms regulating the expression of renin angiotensin system components, the characterization of angiotensin-(1-7) as an endogenous antagonist of the actions of angiotensin II, and the demonstration of the regulatory influence of angiotensin II in the expression of angiotensin converting enzyme 2.

  • Rafael Hern‡ndez-Hern‡ndez/Members

    Rafael Hernandez-Hernandez Member

    Venezuela

    Main concerns in hypertension: Clinical Pharmacology of drugs used for the treatment of hypertension; changes in platelet aggregation induced by antihypertensive drugs and variability during circadian rhythm.

    Also study of the epidemiology of hypertension and other cardiovascular risk factors in Latin America countries.

  • Agustin Ramirez/Members

    Agustin Ramirez Member

    Argentina

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

Eastern Europe & Middle East

  • Tony Heagerty/Chair

    Tony Heagerty Chair

    UK

    My interests in blood pressure focus on the role of small arteries in causing hypertension and target organ damage. Most recently I have been looking at the role of perivascular fat in the pathogenesis of diabetes and hypertension.

  • Mustafa Arici/Members

    Mustafa Arici Member

    Turkey

    My main areas of interest in hypertension are epidemiology of hypertension, salt and blood pressure control, renin-angiotensin system and blood pressure and hypertension and renal protection.

  • Adel Berbari/Members

    Adel Berbari Member

    Lebanon

    1- Relation between renal function and hypertension

    2- Evaluation and effects of arterial stiffness on renal function

    3- Cardiorenal association The effect of the blockade of the renin-angiotensin-aldosterone system in particular

  • Dragan Lovic/Members

    Dragan Lovic Member

    Serbia

    Areas of interest in a field of Hypertension: Obesity , ABPM , pathophisiology of Hypertension and arrithmias.

  • Naftali Stern/Members

    Naftali Stern Member

    Israel

    Areas of interest and research include hormonal control of blood pressure and the vasculature with particular emphasis on the metabolic syndrome; role of sex hormones in arterial physiology; role of the lipoxygenase system in vascular cell signaling and growth, interaction between adipocytes and vascular cells.

Western Europe & North America

  • Michael Weber/Chair

    Michael Weber Chair

    U.S.A.

    I am involved in the contemporary practice of preventative cardiology, with a focus on hypertension. I am currently the editor of the Journal of Clinical Hypertension and so have an excellent opportunity to be aware of new developments and controversies in the field.

    I have a major interest in clinical trials in patients with hypertension or at high cardiovascular risk, and am particularly interested in how current evidence based on this research -- much of which is inconclusive -- can be used to help define hypertension and guide clinical practice.

    I have also been involved in the development of new drugs for treating hypertension and in understanding how they can be used to the greatest clinical advantage in our patients.

  • Bo Carlberg/Members

    Bo Carlberg Member

    Sweden

    Areas of interest:

    • The epidemiology of hypertension
    • The hypertension-stroke connection
    • Blood Pressure in acute stroke Systematic Reviews
    • The process from research to guidelines for cardiovascular diseases in developing countries
  • Guido Grassi/Members

    Guido Grassi Member

    Italy

    Areas of interest:

    • Pathophysiology of hypertension, with particular emphasis on the role of the Sympathetic Nervous System
    • Assessment of target organ damage
    • Blood pressure control
    • Guidelines on hypertension diagnosis and management
  • Hermann Haller/Members

    Hermann Haller Member

    Germany

    Main interests in clinical research:

    • diagnostics and treatment of renovascular hypertension
    • hypertension and the vasculature in diabetes
    • hypertension in organ transplantation
    • novel therapeutic devices such as carotid sinus stimulation and renal sympathetic nerve ablation Main interests in basic science
    • the biology of the vascular wall and endothelial function
    • endothelial cell permeability
    • cell adhesion and inflammation
    • stem cell precursors of the endothelium
  • Roland Schmieder/Members

    Roland Schmieder Member

    Germany

    I have extensive experience in the execution of clinical observational and international multicenter studies.

    My research interests include nephrology, hypertension, non-invasive cardiology and vascular medicine, with a focus on hypertensive damage to the heart, kidneys, arteries and retinal circulation and its treatment.

Awards Committee

  • Stephen Harrap/Chair

    Stephen Harrap Chair

    Australia

    My ongoing commitment to hypertension encompasses clinical (as a specialist physician), research (in human and experimental genetics of blood pressure and its complications) and teaching (as Chair of Physiology) perspectives.

  • Louise Burrell/Members

    Louise Burrell Member

    Australia

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

  • Ernesto Schiffrin/Members

    Ernesto Schiffrin Member

    Canada

    I carry out basic and clinical mechanistic and therapeutic research in high blood pressure, teaching and clinical practice in cardiovascular and internal medicine, and editorial activity in hypertension. I also head a department of medicine in a university hospital.

  • Agustin Ramirez/Members

    Agustin Ramirez Member

    Argentina

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Maciej Tomaszewski/Members

    Maciej Tomaszewski Member

    UK

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Rhian Touyz/Secretary & Forum Officer

    Rhian Touyz President-Elect and Chair, Membership Committee

    UK

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

Communications Committee

  • Bo Carlberg/Officer-at-Large - Young Investigators

    Bo Carlberg Chair

    Sweden

    Areas of interest:

    • The epidemiology of hypertension
    • The hypertension-stroke connection
    • Blood Pressure in acute stroke Systematic Reviews
    • The process from research to guidelines for cardiovascular diseases in developing countries
  • Dylan Burger/Members

    Dylan Burger Member

    Canada

    My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

  • Lars H. Lindholm/Hypertension News

    Lars H. Lindholm Member

    Sweden

    I have been President of the Swedish Society of Hypertension (1989-92), Secretary (the first) of the European Society of Hypertension, ESH (1989-97) , and President of the ISH (2006-8). Since 2009, I have been an honorary member of the British Society of Hypertension.

    My interest in hypertension and its risks started in the late 1970s and I defended my doctoral thesis on this topic in 1994. Since 1998, I am Professor and chairman at the Department of Public Health and Clinical Medicine at Umeå University, Sweden.

  • Neil Poulter/Members

    Neil Poulter Member

    UK

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

Corporate Liaison Committee

  • Louise Burrell/Chair

    Louise Burrell Chair

    Australia

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

  • Hermann Haller/Members

    Hermann Haller Member

    Germany

    Main interests in clinical research:

    • diagnostics and treatment of renovascular hypertension
    • hypertension and the vasculature in diabetes
    • hypertension in organ transplantation
    • novel therapeutic devices such as carotid sinus stimulation and renal sympathetic nerve ablation Main interests in basic science
    • the biology of the vascular wall and endothelial function
    • endothelial cell permeability
    • cell adhesion and inflammation
    • stem cell precursors of the endothelium
  • Cheol-Ho-kim / Members

    Cheol-Ho Kim Member

    Korea

    I am the chief of the Geriatric Centre of Seoul National University Bundang Hospital, working as the Chair of Scientific Affairs for the organizing committee of the ISH 2016 in Seoul, as the Director of Planning for the Korean Society of Hypertension and as a member of the Board of Trustees of the Asian Pacific Society of Hypertension. My main interest is hypertension especially in the elderly and related clinical studies.

  • Neil Poulter/Members

    Neil Poulter Member

    UK

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Kazuaki Shimamoto/Members

    Kazuaki Shimamoto Member

    Japan

    My research interests are; Epidemiology of hypertension, etiology of hypertension especially the role of insulin resistance and adipocytokines, and treatment of hypertension especially the mechanisms of RAS inhibitory drugs.

  • Ji-Guang Wang/Members

    Ji-Guang Wang Member

    China

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

  • Michael Weber/Members

    Michael Weber Member

    U.S.A.

    I am involved in the contemporary practice of preventative cardiology, with a focus on hypertension. I am currently the editor of the Journal of Clinical Hypertension and so have an excellent opportunity to be aware of new developments and controversies in the field.

    I have a major interest in clinical trials in patients with hypertension or at high cardiovascular risk, and am particularly interested in how current evidence based on this research -- much of which is inconclusive -- can be used to help define hypertension and guide clinical practice.

    I have also been involved in the development of new drugs for treating hypertension and in understanding how they can be used to the greatest clinical advantage in our patients.

ISH International Forum

  • Stephen Harrap/President

    Stephen Harrap Chair

    Australia

    My ongoing commitment to hypertension encompasses clinical (as a specialist physician), research (in human and experimental genetics of blood pressure and its complications) and teaching (as Chair of Physiology) perspectives.

    For more information on the President, click here

  • Jeong Bae Park/Members

    Jeong Bae Park Officer

    Korea

    Areas of interest:

    • Structure and functionin small and large artery in experimental and human hypertension
    • Clinical trials
  • Rhian Touyz/Members

    Rhian Touyz President-Elect and Chair, Membership Committee

    UK

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

Lower & Middle Income Countries Outreach Committee

  • Basden Onwubere/Members

    Basden Onwubere Chair

    Nigeria

    My area of interest in High Blood Pressure is in prevention and control. I am also interested in the effect of uncontrolled high blood pressure on the heart.

  • Dorairaj Prabhakaran/Members

    Dorairaj Prabhakaran Member

    India

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence ñ Centre for Cardio-metabolic Risk Reduction in South Asiaî (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Agustin Ramirez /Members

    Agustin Ramirez Member

    Argentina

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Naftali Stern/Members

    Naftali Stern Member

    Israel

    Areas of interest and research include hormonal control of blood pressure and the vasculature with particular emphasis on the metabolic syndrome; role of sex hormones in arterial physiology; role of the lipoxygenase system in vascular cell signaling and growth, interaction between adipocytes and vascular cells.

Membership Committee

  • Rhian Touyz/Chair

    Rhian Touyz President-Elect and Chair, Membership Committee

    UK

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

  • Louise Burrell/Members

    Louise Burrell Member

    Australia

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

  • Hermann Haller/Members

    Hermann Haller Member

    Germany

    Main interests in clinical research:

    • diagnostics and treatment of renovascular hypertension
    • hypertension and the vasculature in diabetes
    • hypertension in organ transplantation
    • novel therapeutic devices such as carotid sinus stimulation and renal sympathetic nerve ablation Main interests in basic science
    • the biology of the vascular wall and endothelial function
    • endothelial cell permeability
    • cell adhesion and inflammation
    • stem cell precursors of the endothelium
  • Cheol-Ho-kim / Members

    Cheol-Ho Kim Member

    Korea

    I am the chief of the Geriatric Centre of Seoul National University Bundang Hospital, working as the Chair of Scientific Affairs for the organizing committee of the ISH 2016 in Seoul, as the Director of Planning for the Korean Society of Hypertension and as a member of the Board of Trustees of the Asian Pacific Society of Hypertension. My main interest is hypertension especially in the elderly and related clinical studies.

  • Dorairaj Prabhakaran/Members

    Dorairaj Prabhakaran Member

    India

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence ñ Centre for Cardio-metabolic Risk Reduction in South Asiaî (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Agustin Ramirez /Ex-Officio ñ International Development

    Agustin Ramirez Member

    Argentina

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte Member

    South Africa

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Kazuaki Shimamoto/Members

    Kazuaki Shimamoto Member

    Japan

    My research interests are; Epidemiology of hypertension, etiology of hypertension especially the role of insulin resistance and adipocytokines, and treatment of hypertension especially the mechanisms of RAS inhibitory drugs.

  • Maciej Tomaszewski/Members

    Maciej Tomaszewski Member

    UK

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Ji-Guang Wang/Members

    Ji-Guang Wang Member

    China

    My research interests in the field of human hypertension include population-based epidemiological studies, randomized clinical trials, structure and function of the vascular system, and pathophysiological studies on the basis of biological markers such as genetic polymorphisms.

New Investigator Committee

Click here to view more about our Working Groups

  • Maciej Tomaszewski/Members

    Maciej Tomaszewski Chair

    UK

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Dylan Burger/Members

    Dylan Burger Member

    Canada

    My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

  • Fadi Charchar/Members

    Fadi Charchar Member

    Australia

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Alta Schutte / New Investigators Liaison Officer

    Alta Schutte New Investigator Committee Liaison Officer

    South Africa

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Praveen Veerabhadrappa/Members

    Praveen Veerabhadrappa Member

    U.S.A.

    My research is focused on the Blood Pressure-measurement/monitoring (ABPM) and the effects of lifestyle modification on endothelial cell function (FMD/IMT) and vascular inflammatory biomarkers in hypertensive subjects.

Past Presidents

  • IH Page USA 1966-1970
  • F Gross Germany 1970-1976
  • JIS Robertson UK 1976-1978
  • A Zanchetti Italy 1978-1980
  • JO Davis USA 1980-1982
  • AE Doyle Australia 1982-1984
  • L Hansson Sweden 1984-1986
  • JH Laragh USA 1986-1988
  • G Mancia Italy 1988-1990
  • PA van Zwieten The Netherlands 1990-1992
  • JP Chalmers Australia 1992-1994
  • K Arakawa Japan 1994-1996
  • JN Cohn USA 1996-1998
  • K-H Rahn Germany 1998-2000
  • A Mimran France 2000-2002
  • LJ Beilin Australia 2002-2004
  • MH Alderman USA 2004-2006
  • LH Lindholm Sweden 2006-2008
  • AM Heagerty UK 2008-2010
  • Stephen Harrap Australia 2010-2012